Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 700 clinical trials
Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia

Children presenting for emergency department (ED) care with bloody diarrhea (i.e. hematochezia) represent a diagnostic challenge. Infectious enteric pathogens - Salmonella, Shigella and Shiga

  • 4 views
  • 26 Jan, 2021
  • 1 location
Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients

The purpose of this study is to evaluate the effectiveness of the drug Crofelemer in the treatment of non-HIV patients with chronic idiopathic diarrhea; to determine the prevalence of

  • 0 views
  • 26 Jan, 2021
  • 1 location
Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

The aim of this study is to evaluate the efficacy and safety of Changkang granule as compared to placebo over a 8-week treatment period and explore TCM syndrome types.

  • 0 views
  • 25 Jan, 2021
  • 7 locations
The Effects of Carbohydrates in Irritable Bowel Syndrome

Food and their components are often reported as gastrointestinal (GI) symptom triggers in patients with IBS. The current interest in dietary management in IBS, has largely focused on the negative effect of poorly absorbed and subsequently fermented carbohydrates (FODMAP - Fermentable Oligo-, Di-, Mono-saccharides And Polyols). These unabsorbed carbohydrates can …

  • 0 views
  • 14 Apr, 2021
  • 1 location
A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms

Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by absence of any organic cause. The vast majority of patients associate their symptoms with specific food consumption, creating the need for developing a new therapeutic approach based on altering the dietary habits. The aim of the study focuses …

  • 14 views
  • 23 Jan, 2021
  • 1 location
A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)

This study will assess the long-term safety of oral Eluxadoline administered to pediatric participants with IBS-D who have completed study intervention in the Phase 2 study 3030-202-002 or the Phase 3 study 3030-303-002.

diarrhea
eluxadoline
  • 0 views
  • 22 Sep, 2021
  • 1 location
A Study of the Efficacy Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome

A new Enteric-Coated Cholestyramine (ECC) capsule has been developed to manage diarrhea associated with Short Bowel Syndrome (SBS) in adults. The formulation is expected to release

parenteral fluids
hysterectomy
parenteral nutrition
small intestine
cholestyramine
  • 1 views
  • 17 Apr, 2021
  • 5 locations
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

frequency of loose stools by the end of treatment.

diarrhea
vancomycin
vancomycin oral capsule
oral vancomycin
  • 6 views
  • 26 Jan, 2021
  • 1 location
16-week Flexible vs. 8-week Semaglutide Titration

treatment. The most common adverse reactions, reported in 5% of patients treated with semaglutide are nausea, vomiting, diarrhea, abdominal pain and constipation. In this trial we plan to explore

  • 0 views
  • 25 Jan, 2021
  • 1 location
Treatment of Mild-moderate Clostridium Difficile Infection (CDI)

> 14 days. Resolution of diarrhea and other symptoms and fecal test parameters will be used to assess clinical effectiveness of Immunotherapy with IM-01 antibodies. Patients will be followed for

  • 0 views
  • 23 Jan, 2021
  • 1 location